Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
Mattace Raso G, Simeoli R, Russo R, Santoro A, Pirozzi C, d'Emmanuele di Villa Bianca R, Mitidieri E, Paciello O, Pagano TB, Orefice NS, Meli R, Calignano A. Mattace Raso G, et al. Among authors: orefice ns. Pharmacol Res. 2013 Oct;76:67-76. doi: 10.1016/j.phrs.2013.07.007. Epub 2013 Aug 2. Pharmacol Res. 2013. PMID: 23917217
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Orefice NS, Alhouayek M, Carotenuto A, Montella S, Barbato F, Comelli A, Calignano A, Muccioli GG, Orefice G. Orefice NS, et al. Among authors: orefice g. Neurotherapeutics. 2016 Apr;13(2):428-38. doi: 10.1007/s13311-016-0420-z. Neurotherapeutics. 2016. PMID: 26857391 Free PMC article. Clinical Trial.
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Damiano S, Sasso A, De Felice B, Terrazzano G, Bresciamorra V, Carotenuto A, Orefice NS, Orefice G, Vacca G, Belfiore A, Santillo M, Mondola P. Damiano S, et al. Among authors: orefice g, orefice ns. Brain Res Bull. 2015 Sep;118:1-6. doi: 10.1016/j.brainresbull.2015.08.009. Epub 2015 Sep 3. Brain Res Bull. 2015. PMID: 26327496 Clinical Trial.
βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.
Audrain M, Souchet B, Alves S, Fol R, Viode A, Haddjeri A, Tada S, Orefice NS, Joséphine C, Bemelmans AP, Delzescaux T, Déglon N, Hantraye P, Akwa Y, Becher F, Billard JM, Potier B, Dutar P, Cartier N, Braudeau J. Audrain M, et al. Among authors: orefice ns. Cereb Cortex. 2018 Nov 1;28(11):3976-3993. doi: 10.1093/cercor/bhx260. Cereb Cortex. 2018. PMID: 29048465
Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice.
Souchet B, Audrain M, Billard JM, Dairou J, Fol R, Orefice NS, Tada S, Gu Y, Dufayet-Chaffaud G, Limanton E, Carreaux F, Bazureau JP, Alves S, Meijer L, Janel N, Braudeau J, Cartier N. Souchet B, et al. Among authors: orefice ns. Acta Neuropathol Commun. 2019 Mar 18;7(1):46. doi: 10.1186/s40478-019-0678-6. Acta Neuropathol Commun. 2019. PMID: 30885273 Free PMC article.
21 results